RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All CDSCO (India) updates
CDSCO (India)
NOTICE
Appointment of Central Compounding Authority Order
Published: 10/28/2026Detected: 10/28/2026

Summary preview

Appointment of a Central Compounding Authority suggests India may establish or formalize centralized oversight for compounding activities, potentially affecting how compounded medicines are authorized, supervised, or…

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
manufacturing
quality
safety
clinical
labeling
#CDSCO
#compounding
#Central Compounding Authority
#India regulation
#pharmacovigilance

Official Source Document
Source Verified

Access the original document directly from INDIA CDSCO.

View Official Document

More from CDSCO (India)

  • Misleading or false claims of the product FatX solution registered under COS-2 vide RC no. RC/COS-003300 by the firm M/s Tekno Midas Aesthetics10/28/2026
  • Digital Monitoring System on the ONDLS portal for monitoring the supply chain of high-risk solvents.10/27/2026
  • Strict compliance with the Drugs Rules, 1945, for testing of raw materials and finished formulations10/27/2026
  • Misleading or false claims of the product FatX solution registered under COS-2 vide RC no. RC/COS-003300 by the firm M/s Tekno Midas Aesthetics10/26/2026
  • WHO Alert on falsified DEFITELIO (Defibrotide) 80 mg/ml concentrate for solution for infusion, B. No. 24GC01A, Exp date 04/2027, Mfg by: Patheon, II Trav. sx Via Morolense, 5, 03013 Ferentino (FR) Italy and Marketing authorisation holder: Gentium S.r.l, Piazza XX Settembre, 2, 22079 Villa Guardia (Como) Italy and identified in India10/26/2026

Get CDSCO (India) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service

    • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.